Qualigen Therapeutics Inc (NASDAQ:QLGN) currently has a daily average trading volume of 12.67M but it saw 2433639 shares traded in last market. With a market cap of 2.68M USD, the company’s current market price of $0.24 came rising about 5.76 while comparing to the previous closing price of $0.22. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.26 and as low as $0.14.
Taking a look at 20-day trading activity of Qualigen Therapeutics Inc (QLGN) gives us an average price of $0.2706, while its current price level is -81.34% below from 52-week high level whereas it is 62.25% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2406 while that of 200 days or SMA-200 reads an average of $0.4475. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.20% during that period while stretching the period over a month that increases to 22.84%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 47.69 which implies that the stock is in neutral territory.
Over the week, QLGN’s stock price is moving -6.96% down while it is 41.97% when we observe its performance for the past one month. Year-to-date it is -57.25% down and over the past year, the stock is showing a downside performance of -79.19%.
Currently, Qualigen Therapeutics Inc’s total number of outstanding shares is 11.38M. Company’s return on equity (ROE) at -1656.23%. Stock’s beta reads -0.82. Stock has a price to sale or P/S ratio amounts to 1.64. Its return on asset (ROA) is -131.95% on average.
